Accordingly, we demonstrated an increase of the mRNA expression of CCL2, a chemokine with a target action to macrophages playing a pivotal role in the liver during early stages of inflammation and fibrosis, especially when these inflammatory processes are linked to NAFLD or NASH [65]. Here, CCL2 is linked to metabolic dysfunction-associated steatotic liver disease.